Needham analyst Alex Henderson downgrades Qualys (NASDAQ:QLYS) from Buy to Hold.
Why Is Outlook Therapeutics Stock Nosediving Today?
Outlook Therapeutics Inc (NASDAQ: OTLK) shares are falling after the company received an FDA complete response letter regarding ONS-5010, an investigational ophthalmic formulation of bevacizumab under development to treat